Publications by authors named "S Fontanet"
On February 6, 2018, the European Atomic Energy Community reduced the annual equivalent dose limit for the lens from 150 to 20 mSv/year, because of its association with cataracts at low radiation doses. Our aim was to estimate the radiation doses received by the lens during endourologic procedures that require fluoroscopy. Multicenter study including prospective data of annual eye dosimeters between 2017 and 2020.
View Article and Find Full Text PDFThe aim of the study was to compare standard high-power laser (with < 80 Hz) to extended frequency (> 100 Hz) lithotripsy during miniPCNL. 40 patients were randomized in to two groups undergoing MiniPCNL. For both groups, the Holmium Pulse laser Moses 2.
View Article and Find Full Text PDFArticle Synopsis
- The study investigates the Hugo™ RAS system, a robotic platform used for robot-assisted partial nephrectomy (RAPN), with no prior data available on its use in this surgical context.
- Ten patients were enrolled, and the study tracked various pre, intra, and post-operative metrics to assess the system's performance.
- Results showed that the Hugo™ RAS system is feasible for RAPN, with manageable complication rates and no positive surgical margins, providing insights for future robotic surgeries using this technology.*
Introduction: Extracorporeal wave lithotripsy (ESWL) is considered a first-line treatment for renal and ureteral stones up to 10-20 mm in diameter. Complications are uncommon, with a reported rate of 0-6% in the literature. Bowel perforation has only been described in a few case reports but requires rapid diagnosis and treatment.
View Article and Find Full Text PDFIntroduction: Several randomized controlled trials (RCTs) have been launched in the last decade to examine the surgical safety and oncological efficacy of robot-assisted (RARC) vs open radical cystectomy (ORC) for patients with bladder cancer. The aim of the study was to perform a systematic review and meta-analysis of RCTs to compare the perioperative and oncological outcomes of RARC vs ORC.
Methods: A literature search was conducted through July 2022 using PubMed/Medline, Embase, and Web of Science databases.